We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

New RNA Extraction Strategies Help Mitigate Shortages in SARS-CoV-2 PCR Components
Industry Insight

As the world continues to battle through the pandemic, developing innovative strategies to expand the availability of extraction, and any other testing components that are facing supply issues, will be an ongoing requirement.

Read More

Exploring the Technology Behind a Blood Test for Alzheimer's Disease
Industry Insight

Technology Networks recently spoke to Quanterix's Kevin Hrusovsky to hear more about how the company's technology is being applied in the pursuit of a biomarker for Alzheimer's disease, a progressive neurodegenerative condition for which diagnosis often occurs after the onset of symptoms.

Read More

Towards a Deeper Understanding of the Proteomic Landscape
Industry Insight

At a recent London Proteomics Discussion Group Meeting, Professor Roman Fischer kicked off the event by addressing the apparent "failure" of proteomics to deliver new clinical biomarkers thus far. Technology Networks sat down with Fischer to discuss spatial proteomics, and to expand on some of the key aspects of his research.

Read More

Transforming Antibody Detection
Industry Insight

Technology Networks recently spoke with Bryan Witherbee, CEO, Ardaza, to learn more about ZIVA, a multiplex label-free biosensor platform, and discuss some of the applications it could benefit.

Read More

Exploring the Use of Plasma Viscosity Testing in Diagnosing COVID-19 Severity
Industry Insight

To learn more about plasma viscosity and how it can be measured, as well as understand how this information could potentially be used to help diagnose and treat COVID-19 patients, Technology Networks spoke with Bernie Benson, MD of Benson Viscometers.

Read More

Real-Time Wastewater Monitoring Enables Rapid COVID-19 Outbreak Detection
Industry Insight

We spoke to Ari Goldfarb, CEO of Kando, about how their wastewater monitoring technology works and how it is being applied to the current monitoring efforts in the COVID-19 pandemic.

Read More

Blood Test Detects Over 50 Different Cancers With a 0.7% False-Positive Rate
Industry Insight

Earlier this year, researchers reported in Annals of Oncology that they had developed a blood test that was able to detect, with 99.3% specificity, more than 50 types of cancer and identify exactly where in the body the cancer had originated – in some cases before any symptoms of the disease had manifested. We spoke to the study’s corresponding author, Michael V. Seiden MD PhD, to learn more.

Read More

Measuring the T Cell Immune Response to COVID-19
Industry Insight

To discover how the strength of a person’s immune response to SARS-CoV-2 can be assessed, and why this is important, Technology Networks spoke with Andrew Makin, VP Medical Affairs, Oxford Immunotec.

Read More

Driving Speed, Sensitivity and Precision in Modern Proteomics
Industry Insight

Technology Networks spoke with Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the company's latest analytical technologies and their capabilities.

Read More

From Genome Engineering to COVID-19 Diagnostic Testing at IGI
Industry Insight

The Innovative Genomics Institute (IGI) has launched an impressive COVID-19 diagnostic testing laboratory at UC Berkeley. Technology Networks spoke with Professor Jennifer Doudna, Executive Director at IGI and Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, to learn exactly how this ambitious effort has been achieved.

Read More

 
Advertisement